HOME >> BIOLOGY >> NEWS
Advance in developing biological strategies to produce hydrogen and sequester carbon dioxide

WASHINGTON, DC Secretary of Energy Spencer Abraham announced today that Department of Energy-funded researchers have achieved a significant scientific advance in their efforts to piece together DNA strands, thereby helping develop new, biological methods to capture carbon dioxide from the atmosphere, produce hydrogen and clean the environment.

Joined by J. Craig Venter, Ph.D., head of the Institute for Biological Energy Alternatives (IBEA), Abraham announced that the IBEA has succeeded in stitching together a genome of a phage, or a virus of bacteria. An article by Dr. Venter and his IBEA colleagues describing their accomplishment is in press with the Proceedings of the National Academy of Sciences.

"Researchers have made an exciting scientific advance that may speed our ability to develop biology-based solutions for some of our most pressing energy and environmental challenges," Secretary Abraham said. IBEA scientists have assembled more than 5,000 bases or building blocks of DNA to create a small artificial virus, a so-called phage that infects bacteria. Bacteriophages do not infect humans. This advance brings us closer to our goal of creating entire microbes that are 100 to 1,000-times larger than the artificial virus created so far.

"With this advance," Abraham said, "it is easier to imagine, in the not-too-distant future, a colony of specially designed microbes living within the emission-control system of a coal-fired plant, consuming its pollution and its carbon dioxide, or employing microbes to radically reduce water pollution or to reduce the toxic effects of radioactive waste."

Dr. Venter, Dr. Hamilton Smith, who was awarded the 1978 Nobel Prize in Physiology, and their IBEA colleagues synthesized a bacteriophage genome from commercially available materials and created an active phage, a harmless microscopic life form that infects bacteria. The researchers accomplished this in 14 days, from start to finish, reducing the
'"/>

Contact: Jeff Sherwood
jeff.sherwood@hq.doe.gov
202-586-5806
DOE/US Department of Energy
13-Nov-2003


Page: 1 2 3

Related biology news :

1. Advances in tumor angiogenesis Dendritic cells co-opted to the dark side
2. Advances in equine cloning may aid insight into human diseases
3. Advanced sensors, computing systems tracking sea animals worldwide
4. Lunch workshop at the American Association for the Advancement of Science (AAAS) Annual Meeting
5. Advances in prosthetic, orthopedic, and audiologic diagnostic tools
6. Advances in micro RNA exploring process of life
7. Advance warning of storms and cyclones with new technique
8. Statement by the Ethics Advisory Board of Advanced Cell Technology, Inc.
9. Advances developed to detect bioterrorist agents could find use in protecting food supplies
10. Advances in gene therapy for hemophilia to be addressed at AAAS lecture
11. UC Irvine Advanced Power and Energy Program awarded $3 million grant by California Energy Commission

Post Your Comments:
(Date:5/21/2013)... USC have found that a class of pharmaceuticals can ... , The drugs, known as "TSPO ligands," are currently ... at the effects of TSPO ligand in young adult ... in aged mice when pathology was quite severe," said ... of Gerontology. "TSPO ligand reduced measures of pathology and ...
(Date:5/21/2013)... Chicago College of Medicine will study gender differences in how ... source -- and how changes in fat metabolism play a ... grant from the National Heart, Lung and Blood Institute. , ... energy. These changes may play a major role in the ... women, says E. Douglas Lewandowski, director of the UIC Center ...
(Date:5/21/2013)... charted the path of insulin action in cells in ... blueprint for understanding what goes wrong in diabetes. ... Professor David James from Sydney,s Garvan Institute of Medical ... of the prestigious journal Cell Metabolism . , ... very important role in the body because it helps ...
Breaking Biology News(10 mins):Drugs found to both prevent and treat Alzheimer's disease in mice 2Do men's and women's hearts burn fuel differently? 2Insight into the dazzling impact of insulin in cells 2Insight into the dazzling impact of insulin in cells 3
(Date:5/21/2013)... England , May 22, 2013 ... novel drug-only formulation of glycopyrronium bromide designed using Prosonix, ... pharmaceutical company developing a portfolio of inhaled Respiratory ... clinical study with PSX1002 that will assess its effect ... of doses in patients with moderate to severe chronic ...
(Date:5/21/2013)... Bellingham, WA (PRWEB) May 21, 2013 ... teacher trainings, and funds for lab equipment, 25 organizations ... relevance and importance of optics and photonics in daily ... Grants . , The organizations, located in 10 countries, ... grants to be awarded by SPIE, the international ...
(Date:5/21/2013)... 2013 Savoury Systems International (SSI), a ... Braddy to Southeastern USA Sales Broker. Braddy’s new role ... in the Southeast. , In 2004 Braddy ... supplier to food processors and industrial manufacturers. Braddy ... food industry and has over 25 years of sales ...
(Date:5/21/2013)... Canada (PRWEB) May 21, 2013 ... is a strong push within the industry to ... and Manufacturing Organizations and pharma companies often means ... frames. , Microtablets, developed in collaboration with Sensidose ... effective outsourcing can bring products to market sooner. ...
Breaking Biology Technology:Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 2Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2
Cached News: